GFT Technologies SE
XMUN:GFT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GFT Technologies SE
XMUN:GFT
|
DE |
|
Elicera Therapeutics AB
F:8E8
|
SE |
|
E
|
Enbridge Inc
DUS:EN3
|
CA |
|
Shenzhen Sunxing Light Alloys Materials Co Ltd
SSE:603978
|
CN |
|
C
|
Citigroup Inc
XHAN:TRVC
|
US |
|
Edion Corp
F:9H2
|
JP |
Balance Sheet
Balance Sheet Decomposition
GFT Technologies SE
GFT Technologies SE
Balance Sheet
GFT Technologies SE
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
35
|
33
|
21
|
21
|
20
|
26
|
33
|
36
|
26
|
33
|
36
|
47
|
38
|
0
|
0
|
72
|
62
|
0
|
0
|
0
|
0
|
0
|
80
|
61
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
80
|
61
|
|
| Cash Equivalents |
35
|
33
|
21
|
21
|
20
|
26
|
33
|
36
|
26
|
33
|
36
|
47
|
38
|
0
|
0
|
72
|
62
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
3
|
3
|
10
|
8
|
4
|
4
|
3
|
3
|
3
|
1
|
1
|
2
|
1
|
48
|
64
|
2
|
1
|
56
|
71
|
71
|
78
|
0
|
0
|
0
|
|
| Total Receivables |
24
|
18
|
19
|
23
|
35
|
49
|
45
|
42
|
55
|
52
|
46
|
76
|
110
|
101
|
121
|
122
|
116
|
137
|
111
|
155
|
185
|
203
|
203
|
215
|
|
| Accounts Receivables |
23
|
17
|
18
|
23
|
34
|
48
|
44
|
42
|
55
|
51
|
44
|
73
|
108
|
95
|
117
|
113
|
109
|
130
|
103
|
148
|
175
|
192
|
187
|
199
|
|
| Other Receivables |
1
|
1
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
3
|
2
|
6
|
4
|
8
|
7
|
7
|
8
|
7
|
10
|
11
|
17
|
16
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
5
|
1
|
1
|
2
|
3
|
2
|
1
|
4
|
2
|
1
|
2
|
1
|
4
|
4
|
5
|
12
|
15
|
10
|
14
|
14
|
22
|
28
|
29
|
28
|
|
| Total Current Assets |
67
|
55
|
51
|
54
|
61
|
81
|
82
|
84
|
86
|
87
|
84
|
126
|
153
|
153
|
191
|
208
|
194
|
204
|
196
|
240
|
285
|
301
|
313
|
304
|
|
| PP&E Net |
6
|
3
|
3
|
3
|
2
|
3
|
3
|
2
|
3
|
3
|
3
|
8
|
18
|
26
|
31
|
29
|
27
|
77
|
68
|
56
|
64
|
60
|
60
|
52
|
|
| PP&E Gross |
6
|
3
|
3
|
3
|
2
|
3
|
3
|
2
|
3
|
3
|
3
|
8
|
18
|
26
|
31
|
29
|
27
|
77
|
68
|
56
|
64
|
60
|
60
|
52
|
|
| Accumulated Depreciation |
14
|
16
|
16
|
10
|
12
|
11
|
12
|
6
|
7
|
8
|
9
|
12
|
15
|
18
|
20
|
23
|
28
|
31
|
31
|
33
|
36
|
37
|
83
|
78
|
|
| Intangible Assets |
1
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
9
|
27
|
30
|
30
|
23
|
27
|
22
|
16
|
11
|
6
|
20
|
34
|
36
|
|
| Goodwill |
27
|
18
|
15
|
15
|
20
|
20
|
20
|
20
|
20
|
36
|
36
|
59
|
99
|
109
|
107
|
102
|
113
|
119
|
120
|
124
|
124
|
163
|
230
|
225
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
7
|
3
|
0
|
1
|
1
|
1
|
3
|
1
|
1
|
1
|
3
|
3
|
2
|
1
|
1
|
|
| Other Long-Term Assets |
10
|
7
|
6
|
6
|
6
|
6
|
7
|
6
|
5
|
4
|
4
|
4
|
4
|
4
|
5
|
6
|
11
|
13
|
14
|
17
|
16
|
17
|
14
|
22
|
|
| Other Assets |
27
|
18
|
15
|
15
|
20
|
20
|
20
|
20
|
20
|
36
|
36
|
59
|
99
|
109
|
107
|
102
|
113
|
119
|
120
|
124
|
124
|
163
|
230
|
225
|
|
| Total Assets |
111
N/A
|
84
-24%
|
76
-9%
|
78
+3%
|
92
+18%
|
112
+21%
|
114
+1%
|
113
0%
|
129
+13%
|
138
+8%
|
132
-5%
|
206
+57%
|
302
+46%
|
327
+8%
|
366
+12%
|
373
+2%
|
373
0%
|
436
+17%
|
415
-5%
|
452
+9%
|
498
+10%
|
563
+13%
|
653
+16%
|
640
-2%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
14
|
11
|
11
|
10
|
16
|
29
|
27
|
24
|
28
|
29
|
20
|
22
|
21
|
11
|
13
|
14
|
14
|
9
|
10
|
12
|
12
|
14
|
13
|
14
|
|
| Accrued Liabilities |
18
|
15
|
12
|
0
|
0
|
0
|
3
|
3
|
0
|
0
|
3
|
3
|
15
|
15
|
16
|
20
|
22
|
24
|
24
|
27
|
26
|
29
|
31
|
32
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
46
|
1
|
18
|
5
|
15
|
26
|
43
|
29
|
9
|
56
|
63
|
76
|
|
| Other Current Liabilities |
11
|
9
|
8
|
20
|
22
|
22
|
18
|
18
|
27
|
25
|
25
|
45
|
59
|
64
|
67
|
98
|
75
|
86
|
86
|
127
|
151
|
155
|
152
|
161
|
|
| Deferred Revenue |
4
|
0
|
0
|
0
|
5
|
3
|
4
|
2
|
0
|
0
|
3
|
0
|
12
|
16
|
25
|
25
|
34
|
40
|
38
|
48
|
63
|
48
|
58
|
57
|
|
| Total Current Liabilities |
44
|
35
|
31
|
30
|
40
|
51
|
48
|
46
|
55
|
54
|
47
|
71
|
141
|
91
|
114
|
138
|
126
|
146
|
163
|
195
|
198
|
253
|
259
|
282
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
39
|
47
|
83
|
86
|
106
|
106
|
142
|
106
|
74
|
73
|
48
|
97
|
72
|
|
| Deferred Income Tax |
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
3
|
6
|
6
|
6
|
3
|
5
|
4
|
4
|
3
|
4
|
8
|
14
|
13
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
1
|
4
|
3
|
2
|
2
|
1
|
2
|
8
|
4
|
7
|
8
|
23
|
43
|
10
|
9
|
11
|
14
|
19
|
21
|
12
|
12
|
9
|
|
| Total Liabilities |
46
N/A
|
37
-20%
|
33
-11%
|
34
+4%
|
43
+26%
|
54
+27%
|
50
-7%
|
48
-5%
|
57
+20%
|
63
+9%
|
52
-18%
|
119
+131%
|
201
+69%
|
202
+1%
|
249
+23%
|
257
+3%
|
245
-5%
|
303
+23%
|
287
-5%
|
291
+2%
|
297
+2%
|
321
+8%
|
381
+19%
|
377
-1%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
|
| Retained Earnings |
29
|
47
|
51
|
50
|
44
|
11
|
5
|
3
|
3
|
7
|
11
|
20
|
33
|
50
|
49
|
56
|
67
|
68
|
72
|
92
|
133
|
174
|
206
|
192
|
|
| Additional Paid In Capital |
67
|
67
|
67
|
67
|
67
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
6
|
1
|
9
|
8
|
3
|
13
|
0
|
0
|
1
|
3
|
17
|
|
| Total Equity |
65
N/A
|
47
-27%
|
43
-8%
|
45
+3%
|
49
+11%
|
58
+17%
|
63
+10%
|
66
+4%
|
71
+8%
|
76
+6%
|
80
+6%
|
87
+9%
|
100
+15%
|
124
+24%
|
117
-6%
|
115
-2%
|
127
+10%
|
133
+5%
|
128
-4%
|
161
+25%
|
201
+25%
|
241
+20%
|
271
+12%
|
263
-3%
|
|
| Total Liabilities & Equity |
111
N/A
|
84
-24%
|
76
-9%
|
78
+3%
|
92
+18%
|
112
+21%
|
114
+1%
|
113
0%
|
129
+13%
|
138
+8%
|
132
-5%
|
206
+57%
|
302
+46%
|
327
+8%
|
366
+12%
|
373
+2%
|
373
0%
|
436
+17%
|
415
-5%
|
452
+9%
|
498
+10%
|
563
+13%
|
653
+16%
|
640
-2%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
|